Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 1/20 | 0.52 |
| ▸ | SCN3A | Q9NY46 | 5/20 | 0.48 |
| ▸ | PARP15 | Q460N3 | 3/20 | 0.45 |
| ▸ | PARP10 | Q53GL7 | 3/20 | 0.45 |
| ▸ | MAOB | P27338 | 4/20 | 0.43 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.41 |
| ▸ | CDC25B | P30305 | 3/20 | 0.41 |
| ▸ | F9 | P00740 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30656254 | 1.00 | SCN9A (0.52) | SCN9ASCN3APARP15PARP10MAOB | |
| SCHEMBL30656154 | 0.89 | SCN9A (0.44) | SCN9ASCN3APARP15PARP10MAOB | |
| SCHEMBL30656302 | 0.89 | SCN9A (0.44) | SCN9ASCN3APARP15PARP10MAOB | |
| SCHEMBL26661099 | 0.87 | EDNRA (0.52) | SCN9AMAOB | |
| SCHEMBL30656189 | 0.85 | SCN9A (0.36) | SCN9ASCN3AMAOB | |
| SCHEMBL30656226 | 0.84 | CD38 (0.37) | SCN9ASCN3AMAOB | |
| SCHEMBL30656258 | 0.84 | CD38 (0.37) | SCN9ASCN3AMAOB | |
| SCHEMBL30656124 | 0.84 | HPGDS (0.37) | SCN9ASCN3AMAOB | |
| SCHEMBL26792937 | 0.83 | PARP10 (0.45) | SCN9ASCN3APARP15PARP10MAOB | |
| SCHEMBL30656142 | 0.83 | PARP10 (0.43) | PARP10MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4532013-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | Katholieke Universiteit Leuven KU Leuven Research & Development (BE) | 2025-04-09 | — | — | EP | claimed |
| WO-2023227697-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-11-30 | — | — | WO | claimed |
| EP-4532013-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | Katholieke Universiteit Leuven KU Leuven Research & Development (BE) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023227697-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-11-30 | — | — | WO | disclosed |